<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0008">
 <label>8</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Reck</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Horn</surname>
    <given-names>L</given-names>
   </name>, 
   <name name-style="western">
    <surname>Novello</surname>
    <given-names>S</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Phase II study of roniciclib in combination with cisplatin/etoposide or carboplatin/etoposide as first-line therapy in patients with extensive-disease small cell lung cancer</article-title>. 
  <source>J Thorac Oncol</source>
  <year>2019</year>;
  <volume>14</volume>:
  <fpage>701</fpage>–
  <lpage>11</lpage>.
  <pub-id pub-id-type="pmid">30677506</pub-id>
 </mixed-citation>
</ref>
